
UnitedHealth Stock Collapse Continues: Here's What This Investor Thinks Will Happen Next
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Since the assassination of Brian Thompson, the CEO of its insurance division, in New York last year, the company has faced mounting scrutiny. Investors are increasingly uneasy about UnitedHealth's transparency, while the public has raised sharp concerns over its claims-handling practices.
Given the reputational setbacks, investor A.J. Button believes the fallout could soon weigh on the company's bottom line.
'Bad PR can lead to brand damage,' he warns, 'which in turn can lead to policyholders taking their business elsewhere.'
That said, Button acknowledges that the company's fundamentals remain relatively strong. UNH still boasts a robust balance sheet and solid profitability metrics, suggesting it has the financial strength to withstand pressure. 'Nevertheless,' Button cautions, 'the issues facing UnitedHealth right now are very real.'
One of the most pressing red flags is the company's exceptionally high claim denial rate, reportedly the highest in the sector, according to multiple sources. While not catastrophic in itself, such a pattern could indicate flawed underwriting or strained claims infrastructure – issues that compound the reputational damage and hint at possible internal mismanagement.
'So,' Button adds, 'UnitedHealth has many qualities, good and bad.' On one hand, its financial footing and history of profitability provide a cushion. On the other, cracks are beginning to show: for fiscal 2024, its combined ratio hit 97.2% – right up against the industry's red line. Button argues that, before investors can have full confidence, the company needs to take meaningful action to shore up its underwriting performance.
Whether that turnaround is underway remains an open question. UnitedHealth recently reinstated former CEO Stephen Helmsley, following the previous leader's departure. But the move has raised eyebrows, given that Helmsley is a longtime insider who presided over many of the company's earlier challenges. His return doesn't exactly scream transformation.
A rebound is still possible – especially if the company takes decisive steps to restore trust and address internal inefficiencies. However, given the scale of its current controversies, Button advises investors to weigh the risks carefully. Even the stock's seemingly low P/E ratio doesn't present a compelling bargain relative to peers in the life and health insurance space.
'When considering a stock like UnitedHealth, with a good track record but an unprecedented new set of risk factors, it pays to be cautious,' the investor summed up.
Can UnitedHealth Stock Bounce Back?
Button assigns a 'low-conviction' buy rating on UNH shares – a nod to its potential, but with more than a few strings attached. (To watch Button's track record, click here)
Wall Street, though, is a bit more upbeat. The stock holds 19 Buy recommendations, 6 Holds, and just 1 Sell, translating to a Moderate Buy consensus rating. With an average price target of $364.96, analysts are eyeing 29% upside from current levels. (See UNH stock forecast)
To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
C3 AI (AI) Loses 10.8% as CEO Steps Down
We recently published . Inc. (NYSE:AI) is one of the worst-performing stocks on Thursday. C3 AI snapped a two-day rally on Thursday, losing 10.84 percent to close at $26 apiece as investors repositioned portfolios following its chief executive's announcement that he was stepping down from his post. In a statement, Inc. (NYSE:AI) said that CEO Thomas Siebel has tendered his resignation due to health reasons, effective upon a successor assuming his post. 'After being diagnosed with an autoimmune disease in early 2025, I have experienced significant visual impairment,' he said. 'For C3 AI to reach its full potential—which I believe is spectacular—the board and I have initiated a search for a new CEO who can take the company to the next level of growth and success. I will remain fully engaged as Chief Executive Officer of until such time as the board appoints my successor, after which I will continue in the role of Executive Chairman, focusing on strategy, product innovation, strategic partner and customer relationships,' he noted. Meanwhile, an analyst from Wedbush said that the chief's resignation presented an opportunity for other firms to acquire Inc. (NYSE:AI). Wedbush gave Inc. (NYSE:AI) an 'outperform' rating and a price target of $35 apiece. While we acknowledge the potential of AI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .
Yahoo
8 minutes ago
- Yahoo
Chipotle Mexican Grill (CMG) Slashes 13% on Disappointing Q2, Outlook
We recently published . Chipotle Mexican Grill, Inc. (NYSE:CMG) is one of the worst-performing stocks on Thursday. Chipotle Mexican Grill fell by 13.34 percent on Thursday to close at $45.74 apiece as investors digested a mixed earnings performance and weak outlook for the rest of the year. In its earnings release, Chipotle Mexican Grill, Inc. (NYSE:CMG) said net income for the second quarter of the year dropped by 4.3 percent to $436 million from $455.7 million in the same period last year. Total revenues, on the other hand, grew by 3 percent to $3.06 billion from $2.97 billion year-on-year, driven by new restaurant openings. Comparable store sales, however, decreased by 4 percent due to lower transactions. Looking ahead, the company expects same-store sales to remain flat year-on-year, but it is working on initiatives to boost performance, including improving execution, introducing new menu innovations, amplifying the rewards program, and expanding globally.3 Pixabay/Public domain Additionally, Chipotle Mexican Grill, Inc. (NYSE:CMG) also expects between 25 and 27 percent of tax rate before discrete items for the full year. While we acknowledge the potential of CMG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Sign in to access your portfolio
Yahoo
8 minutes ago
- Yahoo
Accelerant (ARX) Soars 26% on Market Debut
We recently published . Accelerant Holdings (NYSE:ARX) is one of the best-performing stocks on Thursday. Insurance firm Accelerant Holdings saw its share price surge by 26.19 percent on its first day as a publicly listed company, underscoring strong investor confidence in its stock. In intra-day trading, Accelerant Holdings (NYSE:ARX) rallied by as high as 40 percent to hit $29.45 from its initial public offering price of $21, before paring gains to end the day at $26.5 apiece. The company was able to raise $724 million from its IPO, covering 34.5 million shares. The offering consisted of 20.28 million common shares from Accelerant Holdings (NYSE:ARX) and some 14.18 million shares from other existing shareholders. They had earlier planned on selling 29 million shares at a price ranging from $18 to $20 apiece. Accelerant Holdings (NYSE:ARX) said it will not receive any proceeds from the shares sold by existing shareholders. Founded in 2018, Accelerant Holdings (NYSE:ARX) operates as an insurance marketplace connecting niche sellers with institutional investors. While we acknowledge the potential of ARX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .